Skip to main content
. 2012 Sep 27;7(9):e46149. doi: 10.1371/journal.pone.0046149

Figure 9. Schematic of possible therapeutic targets for silibinin in CEES-induced skin injury pathways identified in our studies.

Figure 9

Possible targets of silibinin (red green arrows); increase or decrease by silibinin (up or down arrows, respectively).